Below is a list of the technologies under development at startups identified in March 2015 and included in the Medtech Startups Database.
- Implanted neuromodulation device for the control of blood pressure.
- Less invasive, catheter-based treatment of congestive heart failure caused by ischemic cardiomyopathy.
- Electrophysiology recording systems for the treatment of atrial fibrillation.
- Transcatheter mitral valve repair.
- Orthopedic surgical instruments.
- Smartphone-enabled stethoscope.
- Bioresorbable device for the non-surgical treatment of aneurysms in patients with Kawasaki Disease.
- Cold-based dilatation catheter system for the treatment of various peripheral lesion types.
- Intraoperative surgical image guidance system.
- Surgical device for bone alignment.
- Bone-fixation for orthopedics and tissue allografts for post-surgery wound care.
- Single-use surgical retractors for use during minimally invasive surgery.
- Developing a cell therapy for Type 1 diabetes.
- Optical targeting and visualization of trajectories in surgical procedures.
- Contract medical technology development.
- Device for the treatment of obstructive sleep apnea.
For a historical listing of technologies at medtech startups, see link.
Fundings for medical technologies thus far in March 2015 stand at $542 million, led by the $57 million funding of EndoChoice, Inc.
Below are the top fundings for the month.
|EndoChoice, Inc., has raised $57 million in a round of funding, according to the company
||Endoscopes and other instrumentation in gastroenterology
|Apollo Endosurgery, Inc., has closed a $50 million secured term loan according to the company
||Minimally invasive endoscopic surgical products for bariatric and gastrointestinal procedures
|Semma Therapeutics has raised $44 million in a Series A round of funding according to the company
||Cell therapy for type I diabetes
|Svelte Medical Systems, Inc., has raised $38.01 million of a planned $48.74 million round of funding according to a regulatory filing
||Drug eluting and other coronary stents
|Auxogyn, Inc., has raised $34.32 million of a planned $40 million round of funding according to a regulatory filing
||Diagnostic and other technologies focused on women’s reproductive health
|SteadyMed Therapeutics, Inc., has raised $39.95 million in its IPO according to press reports
||Patch-pump drug delivery technology
|Hansen Medical, Inc., has raised $35 million in a round of funding according to a regulatory filing
For the complete list of medtech fundings in March 2015, see link.
For a historical list of the individual fundings in medtech, by month, since 2009, see link.
Below is a list of technologies under development at medical technology startups identified in July 2014 and included in the Medtech Startups Database.
- Instrumentation for electrophysiology diagnosis and treatment.
- Products for the treatment of hypertension and other chronic disease by interventional cardiologists
- Surgical stapling device for use during natural orifice transluminal endoscopic surgery.
- Low cost medical technologies to improve patient management in emerging markets.
- Heart valve for the treatment of mitral valve regurgitation
- Thrombectomy catheter
- Microstaple bandage for wound closure.
- Whole-body cryotherapy chambers as well as devices for local cryotherapy and cryosurgery.
- Minimally invasive surgical device for the treatment of glaucoma
- Electrical muscle stimulation.
For a historical listing of medical technologies at startups, see link.
If I had a nickel for every headline like this that ultimately failed, like the technology, to actually achieve the promise, I would be on a tropical beach sipping pina coladas:
“Glucose monitoring for diabetes made easy with a blood-less method” (link)
Technologies in development for less-invasive or non-invasive glucose monitoring are legion, and many are very promising, but you can’t fill out a deposit slip with these promises. Frequently, such alternatives are based on the premise of quantifying blood glucose by sensitively detecting glucose in other fluids (interstitial fluid, tears, saliva, urine, etc.) that do not require the use of lancets to draw blood. However, despite their sensitivity and other sophistication in detecting minute quantities of glucose, their “arm’s length” to actual blood glucose compounds the challenge by requiring that the test reproducibly correlate the sample values with actual, current blood glucose levels.
The challenge stands unanswered, while the burgeoning population of endlessly finger-pricked diabetics remains painfully unsatisfied.
As a practical reality, continuous blood glucose monitors like those from Dexcom and Medtronic offer far more to the diabetic population, not only by avoiding finger pricks but also by revealing the patterns in blood glucose levels over time as a result of activity, carbohydrate intake, insulin bolus, insulin basal rate, stress and countless other patient-specific determinants.
Fundings in medical technology for the month of June totaled $445 million, led by fundings of Benvenue Medical ($64 million) and InSightec ($50 million).
Below are the top fundings in the month.
|Benvenue Medical, Inc., has raised $64 million in a round of funding according to the company
||Minimally invasive implants for spine surgery
|InSightec, Inc., has raised $50 million in a Series D round of funding according to the company
||MR-guided focused ultrasound
|Pixium Vision has raised $46.7 million in an initial public offering according to press reports
||Implants to treat blindness
|OrthoPediatrics Corp. has raised $39 million in a round of funding according to a regulatory filing
||Orthopedic implant technologies designed for pediatric use
|Cheetah Medical, Inc., has raised $33.85 million in a round of funding according to a regulatory filing
||Non-invasive hemodynamic monitoring
|Spinal Kinetics, Inc., has raised $33.85 million of a planned $34.77 million round of funding according to a regulatory filing
||Motion preservation systems, including artificial discs, for degenerative disc disease
For a complete list of medtech fundings in June 2014, see link.
For a full list of the fundings in medtech, by month, since 2009, see link.
By comparison to reconstructive surgery, which is overwhelmingly dominated by one type (reconstruction associated with tumor removal), the global distribution of cosmetic surgery procedures is very fragmented, with more than a dozen different surgeries performed over 100,000 times annually. The dominant procedures remain lipoplasty and breast augmentation:
Worldwide Distribution of Cosmetic Surgery By Type
Source: MedMarket Diligence, LLC; Report #S710.
Below is a list of the new medical technologies under development at startups we identified in May 2014 and added to the Medtech Startups Database.
- Patient positioning system for use in hip replacement and other orthopedic procedures.
- Instrumentation to facilitate hip replacement surgery and other orthopedic instrumentation.
- Drug-coated stent-valve designed to inhibit stenosis, obstruction or calcification of the valve.
- Implants for the treatment of aneurysm.
- Orthopedic implant technologies including a force sensor to measure performance of an orthopedic articular joint.
- Insulin patch pump for treatment of insulin-dependent type 2 diabetes.
- Undisclosed tissue vascular technology
- Rapid, accurate, inexpensive diagnostic devices initially focused on malaria.
- Device for diagnosis and management of diabetic retinopathy.
- Tumor-targeted drug delivery.
- Near infrared technology for blood glucose monitoring in diabetes.
- Non-resorbable films for anti-adhesion.
- Angioplasty double balloon for treatment of peripheral vascular disease.
- Device to reduce the risk of ventilator-associated pneumonia.
- Trocar, sleeve and tip for minimally invasive endoscopic surgery.
For a historical listing of the technologies at medtech startups, see link.